- Home
- CALM vs GH Comparison
CALM vs GH Comparison
Compare CALM & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALM
- GH
- Stock Information
- Founded
- CALM 1957
- GH 2011
- Country
- CALM United States
- GH United States
- Employees
- CALM 3067
- GH N/A
- Industry
- CALM Farming/Seeds/Milling
- GH Medical Specialities
- Sector
- CALM Consumer Staples
- GH Health Care
- Exchange
- CALM Nasdaq
- GH Nasdaq
- Market Cap
- CALM 4.9B
- GH 4.9B
- IPO Year
- CALM 1996
- GH 2018
- Fundamental
- Price
- CALM $100.52
- GH $50.15
- Analyst Decision
- CALM Sell
- GH Strong Buy
- Analyst Count
- CALM 3
- GH 20
- Target Price
- CALM $83.00
- GH $54.35
- AVG Volume (30 Days)
- CALM 788.0K
- GH 2.0M
- Earning Date
- CALM 07-22-2025
- GH 08-06-2025
- Dividend Yield
- CALM 1.88%
- GH N/A
- EPS Growth
- CALM 258.93
- GH N/A
- EPS
- CALM 20.24
- GH N/A
- Revenue
- CALM $3,799,016,000.00
- GH $773,996,000.00
- Revenue This Year
- CALM $76.88
- GH $23.14
- Revenue Next Year
- CALM N/A
- GH $21.42
- P/E Ratio
- CALM $4.97
- GH N/A
- Revenue Growth
- CALM 60.00
- GH 28.20
- 52 Week Low
- CALM $62.59
- GH $20.14
- 52 Week High
- CALM $116.41
- GH $53.42
- Technical
- Relative Strength Index (RSI)
- CALM 52.79
- GH 56.81
- Support Level
- CALM $99.95
- GH $48.90
- Resistance Level
- CALM $102.60
- GH $52.46
- Average True Range (ATR)
- CALM 2.91
- GH 1.97
- MACD
- CALM -0.19
- GH -0.23
- Stochastic Oscillator
- CALM 54.15
- GH 48.74
About CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.